PMC:3852277 / 17511-17618 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/3852277","sourcedb":"PMC","sourceid":"3852277","source_url":"http://www.ncbi.nlm.nih.gov/pmc/3852277","text":"Head-to-head PK studies of Concerta® versus Equasym XL®, Ritalin LA®, Ritalin SR®, Daytrana® and Biphentin®","tracks":[{"project":"NEUROSES","denotations":[{"id":"T226","span":{"begin":27,"end":35},"obj":"CHEBI_31836"},{"id":"T227","span":{"begin":57,"end":64},"obj":"CHEBI_31836"},{"id":"T228","span":{"begin":70,"end":77},"obj":"CHEBI_31836"},{"id":"T236","span":{"begin":83,"end":91},"obj":"CHEBI_6887"}],"attributes":[{"subj":"T226","pred":"source","obj":"NEUROSES"},{"subj":"T227","pred":"source","obj":"NEUROSES"},{"subj":"T228","pred":"source","obj":"NEUROSES"},{"subj":"T236","pred":"source","obj":"NEUROSES"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"NEUROSES","color":"#eca193","default":true}]}]}}